Stocks XMTR

Xometry Consensus Price Target Increased by 11.98% to $127.13

The average one-year price target for Xometry (NASDAQGS:XMTR) (DB:0N5) has been revised to $127.13 / share. This is an increase of 11.98% from the prior estimate of $113.53 dated October 30, 2026. These figures represent aggregate analyst targets compiled by Fintel, and do not constitute a recommendation by Fintel.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $108.07 to a high of $147.00 / share. The average price target represents an increase of 10.63% from the latest reported closing price of $114.91 / share as of November 6, 2026. This target range has widened, with the current target range width at $38.93 compared to the prior width of $36.35, representing a target range width change percent of +7.10%. The current median target is $132.60, which increased from the prior median of $112.20 as of October 30, 2026.

Historically, the average price target has trended upward. As of November 9, 2026, the observed twelve-month high mean target is $127.13, while the observed twelve-month low mean target was $50.49 as of November 9, 2025. The current mean target represents a target change since the 90-day baseline of +29.49% from August 4, 2026.

In terms of recent price performance, Xometry's stock price changed by +22.74% over one week, relative to a baseline close of $93.62 on October 30, 2026. Over one month, the price changed by +3.84% from a baseline close of $110.66 on October 6, 2026. Additionally, Xometry reported its latest earnings on November 3, 2026. The actual EPS was 0.28, which was above the estimated EPS of 0.1886, representing an EPS surprise percent of +48.46%. Actual revenue reached $252,440,000.00, compared to the estimated revenue of $240,271,944.00, a revenue surprise percent of +5.06%.

Several financial firms maintained their ratings on Xometry on November 4, 2026. Cantor Fitzgerald maintained its Overweight grade, Citigroup maintained its Buy grade, Citizens maintained its Market Outperform grade, and JP Morgan maintained its Overweight grade. The current recommendation period as of November 1, 2026, shows a total of 18 recommendations, with 77.8% positive recommendations and 22.2% hold recommendations.

Separate market context shows unusual listed-options activity for Xometry on November 6, 2026. The total options volume reached 1,599, which is 3.56x the average volume of 449. The put/call volume ratio was 0.82.

Xometry is classified under the Environmental & Facilities Services sub-industry. Within this sub-industry, 27 companies are covered, with 8 raised, 6 lowered, and 13 unchanged. The sub-industry median revision percent is 0.00%, and the median implied change percent is +28.95%. In the broader industry, peer companies show mixed target revisions and positive implied changes.

Company name Target revision Implied change
Proto Labs +6.02% +57.31%
3D Systems -47.45% +67.01%
Stratasys 0.00% +90.51%

Take Fintel with you. Download the Fintel app from the App Store or Google Play.

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Xometry, Inc. Find out what the Options Markets think of Xometry, Inc. See our take on Xometry, Inc. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available